Evidence map›Paper›PMID 37389570›Full record

ArticleeLife2023

Bacterial DNA on the skin surface overrepresents the viable skin microbiome.

Ellen M Acosta, Katherine A Little, Benjamin P Bratton, Jaime G Lopez, Xuming Mao, Aimee S Payne, Mohamed Donia, Danelle Devenport, Zemer Gitai

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Skin microbiome and dermatologic disorders.The Journal of clinical investigation · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Diversity of Neurotransmitter-Producing Human Skin Commensals.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ellen M AcostaDepartment of Molecular Biology, Princeton University, Princeton, United States.ORCID 0000-0002-6744-8411
Katherine A LittleDepartment of Molecular Biology, Princeton University, Princeton, United States.ORCID 0000-0001-6993-5312
Benjamin P BrattonDepartment of Molecular Biology, Princeton University, Princeton, United States.ORCID 0000-0003-1128-2560
Jaime G LopezLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, United States.
Xuming MaoDepartment of Dermatology, University of Pennsylvania, Philadelphia, United States.
Aimee S PayneDepartment of Dermatology, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0001-9389-7918
Mohamed DoniaDepartment of Molecular Biology, Princeton University, Princeton, United States.
Danelle DevenportDepartment of Molecular Biology, Princeton University, Princeton, United States.ORCID 0000-0002-5464-259X
Zemer GitaiDepartment of Molecular Biology, Princeton University, Princeton, United States.ORCID 0000-0002-3280-6178
Princeton University · USUniversity of Pennsylvania · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Study Design and Data AnalysisP30AR069589 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice · 2016 to 2026
$8.6M
Mechano-microbiology: how physical forces control bacterial-host interactionsDP1AI124669 · NIAID · PRINCETON UNIVERSITY · PI GITAI, ZEMER · 2015 to 2019
$4.0M
NRSA TrainingTL1TR003019 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI SCOTTO, KATHLEEN W. · 2019 to 2023
$1.9M
NCATS NIH HHS TL1 TR003019NCATS NIH HHS TL1TR003019NIAID NIH HHS DP1 AI124669NIAMS NIH HHS P30 AR069589NIGMS NIH HHS GM007388NIGMS NIH HHS T32 GM007388
6 · The paper itself

Abstract

The skin microbiome provides vital contributions to human health. However, the spatial organization and viability of its bacterial components remain unclear. Here, we apply culturing, imaging, and molecular approaches to human and mouse skin samples, and find that the skin surface is colonized by fewer viable bacteria than predicted by bacterial DNA levels. Instead, viable skin-associated bacteria are predominantly located in hair follicles and other cutaneous invaginations. Furthermore, we show that the skin microbiome has a uniquely low fraction of viable bacteria compared to other human microbiome sites, indicating that most bacterial DNA on the skin surface is not associated with viable cells Additionally, a small number of bacterial families dominate each skin site and traditional sequencing methods overestimate both the richness and diversity of the skin microbiome. Finally, we performed an in vivo skin microbiome perturbation-recovery study using human volunteers. Bacterial 16S rRNA gene sequencing revealed that, while the skin microbiome is remarkably stable even in the wake of aggressive perturbation, repopulation of the skin surface is driven by the underlying viable population. Our findings help explain the dynamics of skin microbiome perturbation as bacterial DNA on the skin surface can be transiently perturbed but is replenished by a stable underlying viable population. These results address multiple outstanding questions in skin microbiome biology with significant implications for future efforts to study and manipulate it.

Indexed as

MicrobiotaSkinAggressionAnimalsDNA, BacterialHumansMiceRNA, Ribosomal, 16SDNA, BacterialRNA, Ribosomal, 16Sbacterial viabilityCutibacterium acnesE. colihumaninfectious diseasemicrobiologymicrobiomeStaphylococcus epidermidis

Identifiers

PMID37389570
PMCPMC10328497
OpenAlexW4377099850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.